Back to search results

IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases

Abroad (travel likely)RecruitingPHASE2

Conditions

Breast Cancer · Axillary Nodal Disease · Female Breast Cancer · Axilla; Breast · Mastectomy; Lymphedema · Tumor, Breast

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California, United States

    Contact: Study coordinator (Clinical Trial Recruitment Navigator) · GroupCancerTrialInformation@cshs.org · 310-423-3713
    Scott Karlan, MD (Sub-investigator)
    Armando Giuliano, MD (Sub-investigator)
    Catherine Dang, MD (Sub-investigator)
    Farin Amersi, MD (Sub-investigator)
    Contact: Principal Investigator (Alice Chung, MD)
    Marissa Boyle, MD (Sub-investigator)
    Kjirsten Carlson, MD (Sub-investigator)
    Stephen Shiao, MD PhD (Sub-investigator)
    Julie Jang, MD (Sub-investigator)
    Michele Burnison, MD (Sub-investigator)
    Amin Mirhadi, MD (Sub-investigator)

  • CS Cancer at Huntington Cancer Center, Pasadena, California, United States

    Study coordinator · 424-314-0177
    Jeannie Shen, MD (Sub-investigator)
    Amy Polverini, MD (Sub-investigator)
    Alicia Terando, MD (Sub-investigator)

  • CS Cancer at Valley Oncology Medical Group, Tarzana, California, United States

    Contact: Study coordinator (Vanessa Vasco) · Vanessa.Vasco@cshs.org
    Lauren DeStefano, MD (Sub-investigator)
Study leads

  • Alice Chung, MD

    Principal Investigator

    Cedars-Sinai Medical Center

View source on ClinicalTrials.gov(opens in a new tab)